Drug MNCs Leap At Chance To Buy Brazil's Ache For Up To $4 Billion
This article was originally published in PharmAsia News
Executive Summary
Multinational drug makers such as Abbott Laboratories, GlaxoSmithKline, Novartis and Pfizer appear to be lining up to buy Ache Laboratories Farmaceuticos, one of Brazil's largest drug makers, which may be seeking to sell for up to $4 billion.